Results
Torrent Pharma Q4 Revenue Up 42% YoY to ₹4197 Crores
Torrent Pharmaceuticals reported a 42% YoY rise in Q4 FY26 consolidated revenue to ₹4,197 crores, with operating EBITDA at ₹1,356 crores.
The Board recommended a final dividend of ₹9 per share and app
